Please select the option that best describes you:
What treatment considerations do you make for elderly patients with relapsed/refractory follicular lymphoma?
Are you more inclined to use non cytotoxic regimens such as R2 or PI3K inhibitors?
Answer from: Medical Oncologist at Academic Institution
Treatment options for R/R FL patients depend not only on the condition of the patient but what was received in 1st line and the duration of that line of therapy. Given that if a patient has received chemo-immunotherapy in the frontline setting and had a prolonged remission (> 5 years), then these...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
Taking age into consideration is of course, important and relevant, but it is not the only or even, oftentimes, the key determinant in treatment decision-making in follicular lymphoma. Age, performance status, comorbidities, mobility, independence (both ADLs as well as travel/transit), patient prefe...